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Background: Amyloidosis cutis dyschromica is a rarely documented variant of cutaneous amyloidosis. To date, only
26 cases have been reported.
Objective: The purpose of this study was to improve the clinical and histopathological data for this variant of
amyloidosis and to highlight the immunohistochemical features of the disease. The published cases were also
reviewed.
Methods: We performed a retrospective review of patients with amyloidosis cutis dyschromica in a single centre.
The clinical, histopathological and immunohistochemical features were documented and analysed.
Observations: We described 10 cases of amyloidosis cutis dyschromica. Six of them were female. Five patients
were from the same family, and the other 5 were sporadic. The distinguishing features of the clinical presentation
included generalised mottled hyper- and hypopigmented macules, which were asymptomatic or mild pruritic. The
typical onset of the lesions occurred in childhood (n = 7) and occasionally after puberty (n = 3). No evidence of
systemic amyloidosis deposition was observed in these cases of amyloidosis cutis dyschromica. Amyloid deposits
were observed in the papillary dermis and were positive for the Congo red stain. An immunohistochemical study
showed that the amyloid expresses cytokeratins CK34βE12 and CK5/6.
Conclusions: We described the largest series of amyloidosis cutis dyschromica to date and reviewed the published
patients. This rare disease is featured by generalised mottled hyper- and hypopigmented lesions, and it is a rare
variant of primary cutaneous amyloidosis without evidence of systemic amyloid deposition. Positive staining for the
cytokeratins CK34βE12 and CK5/6 in amyloidosis cutis dyschromica suggests that the amyloid is derived from
keratinocytes.
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diseaseBackground
Primary cutaneous amyloidosis refers to the extracellular
deposition of amyloid material in previously apparent
normal skin without systemic involvement. The major
variants of primary cutaneous amyloidosis are macular
and lichen [1]. Amyloidosis cutis dyschromica (ACD),
first described in 1970, is a rarely documented variant of
cutaneous amyloidosis [2]. Morishima described its fea-
tures as the following: (i) dotted, reticular hyperpigmen-
tation with hypopigmented macules distributed over
nearly all of the body, (ii) no or little itch, (iii) onset be-
fore puberty and (iv) focal amyloid deposition under the* Correspondence: fanghongzy@sina.com
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reproduction in any medium, provided the orepidermis [2]. To date, there are only 26 published cases
worldwide. Some recently published ACD cases pre-
sented with new characteristics. However, the origin of
the amyloid was not described in most of these pub-
lished cases.
To further understand this disease, we report 10 new
cases of ACD and investigate the origin of the amyloid
materials. We also review the cases of ACD reported in
the literature.Patients and methods
We performed a retrospective case analysis of 10 patients
with ACD who were referred to our dermatology depart-
ment from 2004 to 2012. We retrieved the patients’ clin-
ical histories, clinical findings, laboratory results and
attending physician names. All skin biopsy samples wered. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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μm-thick sections were stained with hematoxylin-eosin
and Congo red. A panel of cytokeratin stains (Additional
file 1: Table S1), including AE1/AE3, CK5/6 and
CK34βE12, was performed on the available tissues.
PubMed and Google Scholar were searched for published
cases in English. The study was approved by the Ethical
Committee of The First Affiliated Hospital, College of
Medicine, Zhejiang University. All patients gave their writ-
ten informed consent.Results
Demographic features
A total of 10 patients with ACD were identified in our
database search from 2004 to 2012 (Additional file 2:
Table S2). Four patients were male, and 6 were female.
The patient age ranged from 17 to 73 years, with an
average age of 38.7 years.Clinical presentation
The clinical features of the 10 patients are presented in
Additional file 2: Table S2. Patients no. 1a to no. 1e were
from the same family. There were no family members
with similar disease for the other 5 patients. All patients
were born to non-consanguineous parents. They had no
photosensitivity, blistering eruption or short stature and
reported no history of extensive sun exposure, any other
cutaneous disorder or systemic disease before the onset
of the lesions.
The cutaneous lesions were asymptomatic or mild
pruritic. The typical lesion onset occurred in childhood
(n = 7) and occasionally after puberty (n = 3). The erup-
tions progressed gradually over years to involve almost
the entire body and stabilised thereafter. The time
elapsed from the initial presentation to the final diagno-
sis varied from 4 years to more than 50 years. The dis-
tinguishing features of the clinical presentation included
generalised mottled hyper- and hypopigmented macules
(Figure 1A, 1B and 1C). Diffuse hyperpigmented smallFigure 1 Clinical presentation of amyloidosis cutis dyschromica. A an
distributed over the entire body (patient 1b). C, However, the lesions on thpapules were noted in one patient (Figure 2A, 2B). The
size of the macules and papules ranged from 2 to
10 mm, and they involved almost the entire body in a
symmetrical pattern. The lesions were more pronounced
on the trunk and the limbs with relative sparing of the
face, hands, feet and neck in all cases (Figure 1C). There
was no telangiectasia, erythema, or atrophy. The nails,
hair, teeth, mucous membranes, soles and palms had a
normal appearance. The systematic examination was un-
remarkable except for one patient with colon cancer.
Laboratory investigations, including blood cell count,
urine analysis, abdominal ultrasonography, and serum
protein electrophoresis, revealed no abnormality.
Histopathological findings
The histopathological findings of specimens from hyper-
and hypopigmented lesions in all cases indicated
homogenous eosinophilic masses in the papillary dermis
and sparse melanophages in the superficial dermis
(Figure 3A). In addition to the features observed in the
hyper- and hypopigmented lesions, specimens from the
lichenoid papules showed mild hyperkeratosis. There were
no significant alterations in the reticular dermis. The eo-
sinophilic material stained positive for Congo red in all
cases (Figure 3B). Similar cytokeratin staining profiles
were found in all cases, with strong positive staining for
CK34βE12 and CK5/6 and faint positivity or absence of
staining for AE1/AE3 (Figure 4A, B).Treatment and outcome
Oral vitamin E and vitamin C were the treatment of
choice in most cases and resulted in minimal improve-
ment. Three patients received oral acitretin at 20 mg per
day; two had a good response within three months, but
the other demonstrated minimal improvement.
Literature findings
The literature data are summarised in Additional file 3:
Table S3. A total of 26 published cases were identified ind B, Generalised mottled hyper- and hypopigmented macules were
e face and distal extremities were mild.
Figure 2 Clinical presentation of amyloidosis cutis dyschromica. In addition to the hyper- and hypopigmented macules, diffuse
hyperpigmented small papules were noted (patient 4).
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26 cases is shown in Figure 5. Four patients did not have
family members with the disease, and the other 21 cases
were familial and distributed among 12 families.
Discussion
We report the largest series of ACD cases to date. Simi-
lar to macular amyloidosis and lichen amyloidosis, the
Asian population is more susceptible to this disease, par-
ticularly Chinese, Japanese and Thai individuals. ACD
was familial in 19 of 36 patients (10 in this series and 26
in the literature); 17 cases were sporadic. However, only
two siblings had consanguineous parents. The onset of
dyschromia occurred before puberty in most patients
and after puberty in only 5 patients (3 patients in our
series and 2 patients in the literature).
Itch is a significant symptom in patients with macular
amyloidosis and lichen amyloidosis, which are the two
most common variants of primary cutaneous amyloid-
osis [18]. The lesions of ACD are generally asymptom-
atic, but patients may express cosmetic concerns. Only 5
patients had a mild itch (2 in our series, 3 in the
literature).
In addition to the characteristic generalised reticular
hyperpigmentation checked with hypopigmented
macules, small hyperpigmented papules were found in 5
patients (1 in our series, 5 in the literature). A clinical
morphology overlap between ACD and other variants of
primary cutaneous amyloidosis has been observed in
published cases [3,6,13]. Presentations of blister (n = 2)
[3], freckles (n = 1) [13] and telangiectasia (n = 2) [13]
have been described. Concurrent with ACD with lichen,
poikiloderma-like, dyschromic and bullous variant of pri-
mary cutaneous amyloidosis was reported in one patient
[6]. Our series lacked any concurrent mucocutaneous
disorders, and the hair, nails, teeth, membranes, palms,
and soles were normal in all of our patients. Erythema
was not found in any of the ACD patients.Although ACD is widely accepted as a primary cutane-
ous amyloidosis, it has been associated with other dis-
eases in a few cases. One case of ACD with generalised
morphea was reported [13]. Two siblings presented
ACD associated with atypical Parkinsonism, spasticity
and motor weakness [5]. Systemic amyloid deposition
could potentially explain the extracutaneous manifesta-
tions of the siblings, but neurological investigations
revealed no evidence of systemic amyloid deposition [5].
The authors postulate that the syndrome in this family
may have been caused by a concomitant mutation of
closely linked genes [5]. In our series, colon carcinoma
was found in one patient when he was 16 years old. The
mechanism of the association is unknown. An ACD
diagnosis may cause concern for treating clinicians be-
cause of the possibility of underlying systemic amyloid-
osis. However, no systemic involvement was detected in
any of the reported ACD patients.
The histopathological findings in our series are similar
to those reported in the literature, with amyloid deposit-
ing in the papillary dermis. Amyloid was observed in the
superficial dermis in 2 published cases [10,18]. It is not
clear why the amyloid deposition was so extensive in the
two patients. Histopathologically papular ACD lesions
also revealed amyloid deposits in the papillary dermis.
The presentation of melanophages in the superficial
dermis suggests damage to the basal epidermis in ACD,
lichen amyloidosis and macular amyloidosis. Although
reports examining the origin of ACD amyloid are rare,
the keratin origin of amyloid has been demonstrated in
lichen amyloidosis and macular amyloidosis [18]. The
damage may then result in keratinocyte deposition and
degenerate to amyloid at the dermo-epidermal junction
[18]. Only 3 reports in the literature reported the keratin
composition of the amyloid in ACD [5,12,16]. However,
only wide-spectrum cytokeratin antibodies or high mo-
lecular weight cytokeratin antibodies were used in these
reports. Wide-spectrum anti-cytokeratin antibodies were
Figure 3 Histopathological manifestation of amyloidosis cutis
dyschromica. A, Histopathology of amyloidosis cutis dyschromica
skin lesions showed homogenous eosinophilic masses in the
papillary dermis and sparse melanophages in the superficial dermis
(patient 1b; hematoxylin-eosin, original magnification: ×400). B, The
Congo red stain showed positivity in the papillary dermal deposits
(original magnification × 400 magnification).
Figure 4 Immunohistochemical profile of amyloidosis cutis
dyschromica. Cytokeratin staining showed that the papillary dermal
deposits were strongly positive for CK34βE12 and CK5/6 in
amyloidosis cutis dyschromica. (patient 5; A, CK34βE12 stain; B, CK5/
6 stain; original magnifications: A, × 400, B, × 400).
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molecular weight cytokeratin was positive in another
patient [5]. In our series, 100% (6/6) of the cases
showed immunohistochemical positivity for CK34βE12
and CK5/6 and negative or faint positive staining for
pan-cytokeratin AE1/AE3. To our knowledge, this is
the first report showing the amyloid staining profile of
CK34βE12 and CK5/6 in ACD. The immunohistopatho-
logical results and limited literature reports strongly sup-
port an epidermal origin of the amyloid.
The occurrence of familial cases and disease onset be-
fore puberty suggests a genetic aetiology of ACD. The
genetic basis of ACD is not known. It has been sug-
gested that genetic factors may lead to the disruption of
DNA repair in keratinocytes [16]. Moriwaki et al.
observed slow DNA repair in keratinocytes due to ultra-
violet C damage and reduced repair following ultravioletB damage [16]. However, the cutaneous findings of all
patients are distributed over the entire skin surface, and
the face, neck, and hands often have a milder presenta-
tion than the non-sun-exposed skin area. This argues
against a primary role of photosensitivity in this disorder.
The differential diagnosis of dyschromatoses is often a
challenge to clinical dermatologists, particularly in
ethnic populations in which this disease is not com-
monly observed [19]. The differential diagnosis of ACD
includes other diseases presenting as dyschromatosis
and other amyloid deposition disorders, including
dyschromatosis universalis hereditaria, xeroderma pig-
mentosum, and poikiloderma-like cutaneous amyloid-
osis [20]. Dyschromatosis universalis hereditaria is also
characterised by the presence of generalised hypopig-
mented and hyperpigmented macules, and it begins
before puberty. However, histologically, no amyloid
deposition has been observed in dyschromatosis univer-
salis hereditaria [21]. Xeroderma pigmentosum may
have a similar dyschromatosis appearance but with
Figure 5 Ethnic distribution of 26 cases of amyloidosis cutis dyschromica from the literature. Most published cases of amyloidosis cutis
dyschromica observed in Asian patients.
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actinic damage beginning in infancy and early childhood,
and skin cancers often develop during the first decade of
life [22]. The clinical features of poikiloderma-like cutane-
ous amyloidosis are similar to those of ACD [23].
Poikiloderma-like cutaneous amyloidosis is characterised
by the presence of reticular hyper- and hypopigmentation
lesions, atrophy and telangiectasia. However, many of the
published patients did not fully express the triad. Diffuse
hyperpigmentation was reported in all described patients,
with telangiectasia, atrophy and lichenoid papules in
some. This variant is associated with photosensitivity,
short stature and palmoplantar keratoderma [23,24]. A
few clinical features overlap between poikiloderma-like
cutaneous amyloidosis and ACD. For example, dotty atro-
phy and vesicles were observed in two siblings with ACD
[3], and telangiectasia and photosensitivity were observed
in one patient with ACD [16].
The treatment of ACD is not well documented. Suc-
cess has been reported with photoprotection, antioxi-
dants and acitretin in some case reports [12]. We used
acitretin in three patients in our series, and a significant
improvement of the skin appearance was observed in
two. Therefore, acitretin may be a promising drug for
treating the disease.
A major limitation of our series and the published litera-
ture regarding ACD continues to be small sample size.
ACD is a rare disease; therefore, it is very difficult to identify
sample sizes large enough to reach significant conclusions.Conclusions
We report 10 new cases of ACD. The distinguishing
features of the clinical presentation included generalised
mottled hyper- and hypopigmented macules. No evi-
dence of systemic amyloidosis deposition was found in
these patients. Amyloid deposits were observed in the
papillary dermis. Positive staining for cytokeratins
CK34βE12 and CK5/6 in amyloidosis cutis dyschromica
suggests that the amyloid is derived from keratinocytes.Additional files
Additional file 1: Table S1. The manufacturers of the antibodies used
in this study and the keratins recognised.
Additional file 2: Table S2. Clinical and histological data of patients
with amyloidosis cutis dyschromica: current series.
Additional file 3: Table S3. Clinical and histological data of patients
with amyloidosis cutis dyschromica: a review of published cases.
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